U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 17:50:10 GMT 2023
Edited
by admin
on Sat Dec 16 17:50:10 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type UNKNOWN
Record UNII
0IVD6ASY0W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LORVOTUZUMAB MERTANSINE
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
lorvotuzumab mertansine [INN]
Common Name English
MAYTANSINOID DM1-CONJUGATED HUMANIZED MONOCLONAL ANTIBODY N901
Common Name English
IMGN-901
Code English
HUN901-DM1
Code English
IMGN901
Code English
BB-10901
Code English
HUN-901DM1
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD56 ANTIGEN) (HUMAN-MOUSE MONOCLONAL HUN901 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUN901 LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(3-((3-CARBOXY-1-METHYLPROPYL)DITHIO)-1-OXOPROPYL)-N2'-DEACETYLMAYTANSINE
Common Name English
LORVOTUZUMAB MERTANSINE [USAN]
Common Name English
HUN-901-DM1
Code English
Lorvotuzumab mertansine [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
FDA ORPHAN DRUG 311010
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
FDA ORPHAN DRUG 322610
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
FDA ORPHAN DRUG 300309
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
NCI_THESAURUS C575
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C38714
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL2109484
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
USAN
WW-83
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
INN
9299
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
DRUG BANK
DB12089
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
WIKIPEDIA
LORVOTUZUMAB MERTANSINE
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
CAS
1008106-64-6
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
FDA UNII
0IVD6ASY0W
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL1743037
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
EVMPD
SUB128695
Created by admin on Sat Dec 16 17:50:10 GMT 2023 , Edited by admin on Sat Dec 16 17:50:10 GMT 2023
PRIMARY
From To
1_22 1_96
1_145 1_201
1_262 1_322
1_368 1_426
2_22 2_96
2_145 2_201
2_262 2_322
2_368 2_426
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
1_221 3_219
2_221 4_219
1_227 2_227
1_230 2_230
Glycosylation Link Type Site
N 1_298
N 2_298
Related Record Type Details
Structure of MERTANSINE
TOXIN -> CONJUGATE
NEURAL CELL ADHESION MOLECULE 1
TARGET->LIGAND
Related Record Type Details
LORVOTUZUMAB MERTANSINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966